Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Parkinson's Disease

Free Subscription 19.01.2026 1 BMC Neurol 1 Brain Res 1 Exp Brain Res 1 Exp Neurol 2 J Neural Transm (Vienna) 5 Mov Disord 3 Neurobiol Dis 2 Neurology 1 Neuroscience 1 Rev Neurol (Paris)

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Neurol

1. ZHANG T, Pei C, Jin F, Zhou Y, et al
   Exploring eye movement abnormalities as objective biomarkers for Parkinson's disease utilizing virtual reality-based eye tracking.
   BMC Neurol. 2026 Jan 14. doi: 10.1186/s12883-026-04634.
   PubMed        
   
   

   
   Brain Res

2. SHARMA V, Verma R, Sharma P, Singh TG, et al
   Programmed cell death pathways in Parkinson's disease: Spotlight on ferroptosis and pyroptosis.
   Brain Res. 2026 Jan 11:150165. doi: 10.1016/j.brainres.2026.150165.
   PubMed         Abstract available
   
   

   
   Exp Brain Res

3. JIANG Q, Gao Y, Yuan Y, Li W, et al
   A cross-sectional study of the association between the lymphocyte to high-density lipoprotein ratio and pain in parkinson's disease.
   Exp Brain Res. 2026;244:22.
   PubMed         Abstract available
   
   

   
   Exp Neurol

4. HAJIBABAEI M, Jafarvand B, Beirami E, Valian N, et al
   Imipramine improves motor impairments in a rat model of Parkinson's disease induced by 6-hydroxydopamine; the role of oxidative stress and neurotrophic factors.
   Exp Neurol. 2026 Jan 13:115646. doi: 10.1016/j.expneurol.2026.115646.
   PubMed         Abstract available
   
   

   
   J Neural Transm (Vienna)

5. MARSCHOUN S, Treven M, Brucke C, Lehrner J, et al
   The impact of depressive symptoms on 5-year all-cause mortality in patients with parkinson's disease treated with and without deep brain stimulation.
   J Neural Transm (Vienna). 2026 Jan 16. doi: 10.1007/s00702-026-03102.
   PubMed         Abstract available
   
   
6. VORUZ P, Verin M, Peron JA
   Is motor asymmetry a predictor of non-motor outcomes in Parkinson's disease?
   J Neural Transm (Vienna). 2026 Jan 12. doi: 10.1007/s00702-025-03080.
   PubMed         Abstract available
   
   

   
   Mov Disord

7. OLSZEWSKA DA, Soto-Beasley AI, McCarthy A, Cerquera-Cleves C, et al
   The Assessment of RAB32 p.Ser71Arg Variant Prevalence in Parkinson's Disease Across Selected African, European, and South American Cohorts.
   Mov Disord. 2026 Jan 16. doi: 10.1002/mds.70175.
   PubMed        
   
   
8. BALACHANDAR A, Boogers A, Naghdlou S, Lozano AM, et al
   Beta-Band and Aperiodic Activity Across New and Chronic Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.
   Mov Disord. 2026 Jan 14. doi: 10.1002/mds.70198.
   PubMed         Abstract available
   
   
9. MARTINEZ-NUNEZ AE, Mills KA, Seemiller J, Morrow CB, et al
   Early Autonomic Burden in Prodromal Parkinson's Disease Predicts Cognitive Impairment.
   Mov Disord. 2026 Jan 14. doi: 10.1002/mds.70202.
   PubMed         Abstract available
   
   
10. ZHANG X, Flores-Torres MH, Christine CW, Bjornevik K, et al
    Intake of Folate, Vitamin B6, and Vitamin B12 Before and After Disease Diagnosis and the Risk of Death in Individuals with Parkinson's Disease.
    Mov Disord. 2026 Jan 12. doi: 10.1002/mds.70178.
    PubMed         Abstract available
    
    
11. LIZARRAGA KJ, Wang L, McDermott MP, Lang AE, et al
    From Molecules to Populations: Is There a Role for Vitamin B6 in Parkinson's Disease?
    Mov Disord. 2026 Jan 12. doi: 10.1002/mds.70189.
    PubMed        
    
    

    
    Neurobiol Dis

12. FENG Y, Zhang W, Zhang D, Xu Y, et al
    Cerebellar contributions to cognitive deterioration in Parkinson's disease: Insights from multi-omics and longitudinal data.
    Neurobiol Dis. 2026 Jan 14:107275. doi: 10.1016/j.nbd.2026.107275.
    PubMed         Abstract available
    
    
13. MARANO M, Zizzo C, Cavallieri F, Avenali M, et al
    Association between plasma glucosylsphingosine levels and dyskinesia burden in GBA1-related Parkinson's disease.
    Neurobiol Dis. 2026 Jan 13:107271. doi: 10.1016/j.nbd.2026.107271.
    PubMed         Abstract available
    
    
14. BOONSTRA J, Michielse S, Temel Y, Jahanshahi A, et al
    Ultra-high-field (9.4 T) ex vivo diffusion MRI tractography reveals microstructural differences in Parkinson's disease motor subtypes.
    Neurobiol Dis. 2026;219:107266.
    PubMed         Abstract available
    
    

    
    Neurology

15. COUGHLIN DG, Adler CH, Barbosa W, Feuerstein J, et al
    CSF alpha-Synuclein Seed Amplification Assays and Skin Immunofluorescence: Clinical Applications, Research Opportunities, and Knowledge Gaps.
    Neurology. 2026;106:e214648.
    PubMed         Abstract available
    
    
16. DIAZ-GALVAN P, Franco-Rosado P, Silva-Rodriguez J, Castro-Labrador S, et al
    Association of Physical Exercise With Structural Brain Changes and Cognitive Decline in Patients With Early Parkinson Disease.
    Neurology. 2026;106:e214455.
    PubMed        
    
    

    
    Neuroscience

17. MACEDO TO, Cabral LM, Miranda NC, Scorza FA, et al
    Omega-3 supplementation prevents functional and neural respiratory damage present in an animal model of Parkinson's disease.
    Neuroscience. 2026 Jan 14:S0306-4522(26)00040.
    PubMed         Abstract available
    
    

    
    Rev Neurol (Paris)

18. CLERET DE LANGAVANT L, Mouton A, de Gardelle V, Kouider S, et al
    Visual misperceptions in favour of living beings in Parkinson's disease: A psychophysical study.
    Rev Neurol (Paris). 2026 Jan 15:S0035-3787(26)00002.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.